top of page
Image by Vruyr Martirosyan
logo_1.png
Publications

Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.

2009

Clin Chest Med

Migliori GB, D’Arcy Richardson M, Sotgiu G, et al.

DOI:

10.1016/j.ccm.2009.08.015

MDR-TB and XDR-TB: drug resistance and treatment outcomes.

2009

Eur Respir J

Migliori GB, Sotgiu G, D’Arcy Richardson M, et al.

DOI:

10.1183/09031936.00059409

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.

2009

Eur Respir J

Migliori GB, Eker B, Richardson MD, et al.

DOI:

10.1183/09031936.00009509

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.

2009

Eur Respir J

Mack U, Migliori GB, Sester M, et al.

DOI:

10.1183/09031936.00120908

Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study.

2009

Am J Respir Crit Care Med

Jafari C, Thijsen S, Sotgiu G, et al.

DOI:

10.1164/rccm.200904-0557OC

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.

2008

Eur Respir J

Ruhwald M, Bodmer T, Maier C, et al.

DOI:

10.1183/09031936.00055508

Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.

2008

Clin Infect Dis

Migliori GB, Lange C, Girardi E, et al.

DOI:

10.1086/528875

Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

2008

Eur Respir J

Migliori GB, Lange C, Girardi E, et al.

DOI:

10.1183/09031936.00159807

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

2008

Eur Respir J

Migliori GB, Lange C, Centis R, et al.

DOI:

10.1183/09031936.00028708

Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.

2008

PLoS One

Goletti D, Carrara S, Butera O, et al.

DOI:

10.1371/journal.pone.0003417

Multidrug- and extensively drug-resistant tuberculosis, Germany.

2008

Emerg Infect Dis

Eker B, Ortmann J, Migliori GB, et al.

DOI:

10.3201/eid1411.080729

Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey.

2008

Eur Respir J

Bothamley GH, Ditiu L, Migliori GB, et al.

DOI:

10.1183/09031936.00011708

Extensively drug-resistant tuberculosis, Italy and Germany.

2007

Emerg Infect Dis

Migliori GB, Ortmann J, Girardi E, et al.

DOI:

10.3201/eid1305.070200

Clinical and operational value of the extensively drug-resistant tuberculosis definition.

2007

Eur Respir J

Migliori GB, Besozzi G, Girardi E, et al.

DOI:

10.1183/09031936.00077307

Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy.

2007

Eur Respir J

Losi M, Bossink A, Codecasa L, et al

DOI:

10.1183/09031936.00067307

bottom of page